TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
CDXS

Codexis Inc

Healthcare · Biotechnology

1.30$ -1.5% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CDXS
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
+18.4% +16.8% +2.4% +21.1% +13.0% +0.9% +51.7% +32.3% -49.4% -15.4% +18.6%
-32.3% +48.1% +46.9% -11.9% +23.9% -12.1% +61.6% +71.3% -66.3% +27.2% -42.7%
+37.7% +11.0% -8.7% +34.4% +10.1% +4.7% +49.2% +21.8% -43.0% -24.9% +41.8%
-9.1% +7.5% +33.4% +1.1% +13.0% +30.4% +26.6% +43.2% -26.5% -21.4% +13.1%
+1.7% +13.9% +14.1% +1.0% +7.5% +11.3% +40.7% +5.2% +2.1% +4.2% -14.6%
-3.8% +10.8% +23.1% +1.0% +10.3% +21.2% +32.8% +28.7% -7.4% -19.0% -2.2%
+5.6% +215.8% +145.0% +356.5% +673.2% -7.4% +57.3% -80.9% +751.8% -15.3% -53.7%
-145.7% +1,894.1% -44.2% +46.0% -75.0% -50.7% +38.2%

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?